Hazelden just sent a newsletter that included a teaser about the rationale for their adoption of Suboxone over methadone. It links to this article that describes their reasoning this way: We found that buprenorphine was a better medication for our patient population and our goals of transitional use of MAT versus long-term medication maintenance. While methadone … Continue reading Hazelden shares rationale for Suboxone over methadone
Author: Jason Schwartz
Overdose – How protective are knowledge and medication?
Jana Burson provides a synopsis of a recent study on the role of the user's knowledge in OD. (Her blog provides her perspective as a doctor who prescribes buprenorphine. It is worth your time.) The findings will not be a surprise to anyone who talks with injection users about their knowledge and experience. The authors … Continue reading Overdose – How protective are knowledge and medication?
Recovery Rising by Bill White
I just learned that Bill White's memoir Recovery Rising: A Retrospective of Addiction Treatment and Recovery Advocacy is available as an e-book on Amazon. The paper copy should be available soon. Bill described it this way: I have worked in the arenas of addiction treatment, recovery research, and recovery advocacy for nearly half a century … Continue reading Recovery Rising by Bill White
Another hustle. Google steps in. (Thank you, Google.)
It's the kind of thing that 99.9% of people would never know, but addiction treatment related keywords have long been the most expensive keywords in Google AdWords. By far. There are treatment programs with, say, 80 beds that have 100 websites. Some identify the provider, most do not. A few years back I published a … Continue reading Another hustle. Google steps in. (Thank you, Google.)
“I’m afraid of never finding people that understand”
I recently listened to this episode from the podcast Rumble Strip. Erica Heilman interviews a high school senior whose mom and grandmother are addicted. She's a really impressive young woman. I hope she's doing well in college. (This was recorded a year or two ago.) This interview does a great job illuminating the effects of … Continue reading “I’m afraid of never finding people that understand”
Methadone in a disaster
I've been thinking about methadone patients in Florida over the last few days. I can't imagine. Vox has a nice first person piece on what it's like. “It's awful. I haven't dosed in 5 days.” The message popped up on my Facebook feed on August 29, a day after Hurricane Harvey first hit Texas. A … Continue reading Methadone in a disaster
The new normal
The Cincinnati Enquirer has a new piece on one week in the heroin epidemic in Cincinnati. It's worth your time. Here's the closing: It's almost midnight on the last day of another week, and the heroin epidemic has done its damage. 18: Deaths known or suspected to be the result of overdoses. 180: Overdoses reported … Continue reading The new normal
A closer look at the evidence
Someone sent this document today and highlighted this statement, "The evidence of the effectiveness of MAT is overwhelmingly positive. 115, 116, 117" That statement provides 3 sources: 115 Addiction Treatment Forum. MAT with Methadone or Burprenorphine: Assessing the Evidence for Effectiveness. February 10, 2014. http://atforum.com/2014/02/mat-with-methadone-orbuprenorphine-assessing-the-evidence-for-effectiveness/. Accessed October 31, 2016. 116 Fullerton CA, Kim M, Thomas CP, … Continue reading A closer look at the evidence
How do we know if we do not ask?
Recovery Science shared a couple of qualitative studies on the experiences of MAT patients. The first identified 7 themes: Patients may not be aware of treatment alternatives Treatment expectations and goals may differ between clinicians and patients Prior experiences with buprenorphine or methadone influence treatment decisions and expectations Accountability and structure facilitate treatment engagement … Continue reading How do we know if we do not ask?
1 in 12 US physicians received a payment involving an opioid
From the American Journal of Public Health: Approximately 1 in 12 US physicians received a payment involving an opioid during the 29-month study. These findings should prompt an examination of industry influences on opioid prescribing. That's not 1 in 12 pain specialists, or 1 in 12 addiction medicine specialists, that's 1 in 12 US physicians. … Continue reading 1 in 12 US physicians received a payment involving an opioid
